These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9041182

  • 1. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
    Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB.
    Cancer Res; 1997 Mar 01; 57(5):837-41. PubMed ID: 9041182
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG, Jen J, Merlo A, Baylin SB.
    Cancer Res; 1996 Feb 15; 56(4):722-7. PubMed ID: 8631003
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
    Malumbres M, Pérez de Castro I, Santos J, Meléndez B, Mangues R, Serrano M, Pellicer A, Fernández-Piqueras J.
    Oncogene; 1997 Mar 20; 14(11):1361-70. PubMed ID: 9178896
    [Abstract] [Full Text] [Related]

  • 4. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
    Malumbres M, Pérez de Castro I, Santos J, Fernández Piqueras J, Pellicer A.
    Oncogene; 1999 Jan 14; 18(2):385-96. PubMed ID: 9927195
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
    Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS.
    Clin Cancer Res; 1999 Oct 14; 5(10):2704-13. PubMed ID: 10537333
    [Abstract] [Full Text] [Related]

  • 6. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 14; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

  • 7. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
    Güran S, Bahçe M, Beyan C, Korkmaz K, Yalçin A.
    Haematologia (Budap); 1998 Nov 15; 29(3):181-93. PubMed ID: 10069444
    [Abstract] [Full Text] [Related]

  • 10. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M, Dhat R, Price CM.
    Oncogene; 1997 Nov 20; 15(21):2609-14. PubMed ID: 9399648
    [Abstract] [Full Text] [Related]

  • 11. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF.
    Haematologica; 1998 Sep 20; 83(9):771-7. PubMed ID: 9825572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA, Kimura T, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF.
    Leuk Res; 2004 Dec 20; 28(12):1293-301. PubMed ID: 15475071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p16ink4a gene and hematological malignancies.
    Quesnel B, Preudhomme C, Fenaux P.
    Leuk Lymphoma; 1996 Jun 20; 22(1-2):11-24. PubMed ID: 8724524
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
    Omura-Minamisawa M, Diccianni MB, Batova A, Chang RC, Bridgeman LJ, Yu J, Pullen J, Bowman WP, Yu AL.
    Clin Cancer Res; 2000 Apr 20; 6(4):1219-28. PubMed ID: 10778944
    [Abstract] [Full Text] [Related]

  • 20. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui CH, Sherr CJ.
    Blood; 1995 May 01; 85(9):2321-30. PubMed ID: 7727766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.